Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	May 31, 2022	May 31, 2021
Cash flows from operating activities:
Net loss	$ (342,822)	$ (48,707)
Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment	299,705
Depreciation and amortization expense	11,576	8,696
Amortization of deferred contract acquisition costs	817	602
Change in fair value of contingent consideration		10,460
Deferred income taxes	(3,999)
Noncash interest expense	419	379
Stock-based compensation expense	19,389	7,675
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable and unbilled revenue	2,323	(409)
Accounts payable and accrued expenses	(1,258)	268
Deferred contract acquisition costs	(924)	(507)
Deferred revenue and due to customers	862	7,643
Accrued compensation	(15,598)	(13,247)
Other liabilities	(240)	(82)
Other assets	(711)	(385)
Net cash used in operating activities	(30,461)	(27,614)
Cash flows from investing activities:
Purchase of marketable securities		(99,998)
Capitalized software development costs	(766)
Purchases of property and equipment	(506)	(701)
Cash paid for acquisition, net of cash acquired		(228,013)
Net cash used in investing activities	(1,272)	(328,712)
Cash flows from financing activities:
Proceeds from stock option exercises	358	1,991
Payments of equity issuance costs		(23)
Payment of debt issuance costs		(8,101)
Payment for purchase of capped calls		(34,443)
Proceeds from employee stock purchase plan	1,150	1,026
Proceeds from borrowings on debt		287,500
Net cash provided by financing activities	1,508	247,950
Net decrease in cash and cash equivalents	(30,225)	(108,376)
Cash and cash equivalents, beginning of period	365,853	433,884
Cash and cash equivalents, end of period	335,628	325,508
Supplemental cash flow information:
Interest paid	769	51
Fixed assets included in accounts payable	228	292
Other receivable related to stock option exercises	5	247
Income taxes paid	$ 22	31
Common stock issued in connection with acquisition		116,187
Replacement awards issued in connection with acquisition		1,520
Debt issuance and offering costs included in accounts payable and accrued expenses		$ 304